(HLT) Hilton Worldwide Holdings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US43300A2033
Stock: Hotel Rooms, Timeshares
Total Rating 57
Risk 62
Buy Signal 0.06
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.22% |
| Yield on Cost 5y | 0.54% |
| Yield CAGR 5y | 10.06% |
| Payout Consistency | 75.8% |
| Payout Ratio | 10.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.0% |
| Relative Tail Risk | -0.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.56 |
| Alpha | 7.53 |
| Character TTM | |
|---|---|
| Beta | 0.916 |
| Beta Downside | 0.945 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.35% |
| CAGR/Max DD | 1.12 |
Description: HLT Hilton Worldwide Holdings January 28, 2026
Hilton Worldwide Holdings Inc. (NYSE: HLT) is a global hospitality firm that manages, franchises, owns, and leases hotels and resorts across 12 brands ranging from luxury (Waldorf Astoria, Conrad) to economy (Hampton, Tru). Its operations are split between a Management & Franchise segment, which generates fee-based revenue, and an Ownership segment, which contributes earnings from property assets. The company’s footprint spans North, Central, and South America, Europe, the Middle East, Africa, and the Asia-Pacific.
As of FY 2023, Hilton reported $9.5 billion in total revenue, with RevPAR (Revenue per Available Room) up 12% YoY in its core North American market, reflecting strong leisure travel demand. Occupancy rates in the Asia-Pacific region reached 71% in Q4 2024, the highest quarterly level since 2019, driven by easing visa restrictions and robust inbound tourism. The firm’s pipeline includes over 1,200 new rooms slated for opening by 2026, a figure that aligns with the industry-wide supply deficit projected to keep average daily rates (ADR) above inflationary pressures.
For a deeper, data-rich assessment of Hilton’s valuation dynamics, you may find ValueRay’s analytical tools useful for further research.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.67b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 3.82 > 1.0 |
| NWC/Revenue: -13.46% < 20% (prev -8.35%; Δ -5.11% < -1%) |
| CFO/TA 0.15 > 3% & CFO 2.51b > Net Income 1.67b |
| Net Debt (11.29b) to EBITDA (2.76b): 4.09 < 3 |
| Current Ratio: 0.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (240.0m) vs 12m ago -3.61% < -2% |
| Gross Margin: 27.81% > 18% (prev 0.27%; Δ 2753 % > 0.5%) |
| Asset Turnover: 70.42% > 50% (prev 65.91%; Δ 4.51% > 0%) |
| Interest Coverage Ratio: 4.23 > 6 (EBITDA TTM 2.76b / Interest Expense TTM 612.0m) |
Altman Z'' -0.05
| A: -0.09 (Total Current Assets 3.12b - Total Current Liabilities 4.70b) / Total Assets 16.64b |
| B: -0.11 (Retained Earnings -1.77b / Total Assets 16.64b) |
| C: 0.16 (EBIT TTM 2.59b / Avg Total Assets 16.66b) |
| D: -0.12 (Book Value of Equity -2.48b / Total Liabilities 21.53b) |
| Altman-Z'' Score: -0.05 = B |
Beneish M -3.02
| DSRI: 0.97 (Receivables 1.65b/1.60b, Revenue 11.73b/11.00b) |
| GMI: 0.98 (GM 27.81% / 27.34%) |
| AQI: 1.08 (AQ_t 0.79 / AQ_t-1 0.73) |
| SGI: 1.07 (Revenue 11.73b / 11.00b) |
| TATA: -0.05 (NI 1.67b - CFO 2.51b) / TA 16.64b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of HLT shares?
As of February 07, 2026, the stock is trading at USD 314.38 with a total of 1,650,867 shares traded.
Over the past week, the price has changed by +5.32%, over one month by +7.19%, over three months by +18.58% and over the past year by +16.53%.
Over the past week, the price has changed by +5.32%, over one month by +7.19%, over three months by +18.58% and over the past year by +16.53%.
Is HLT a buy, sell or hold?
Hilton Worldwide Holdings has received a consensus analysts rating of 3.62.
Therefor, it is recommend to hold HLT.
- StrongBuy: 7
- Buy: 3
- Hold: 15
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the HLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 296.4 | -5.7% |
| Analysts Target Price | 296.4 | -5.7% |
| ValueRay Target Price | 390.8 | 24.3% |
HLT Fundamental Data Overview February 04, 2026
P/E Trailing = 44.0305
P/E Forward = 32.3625
P/S = 14.6298
P/EG = 1.6679
Revenue TTM = 11.73b USD
EBIT TTM = 2.59b USD
EBITDA TTM = 2.76b USD
Long Term Debt = 11.60b USD (from longTermDebt, last quarter)
Short Term Debt = 35.0m USD (from shortTermDebt, last quarter)
Debt = 12.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.29b USD (from netDebt column, last quarter)
Enterprise Value = 82.54b USD (71.25b + Debt 12.35b - CCE 1.06b)
Interest Coverage Ratio = 4.23 (Ebit TTM 2.59b / Interest Expense TTM 612.0m)
EV/FCF = 35.32x (Enterprise Value 82.54b / FCF TTM 2.34b)
FCF Yield = 2.83% (FCF TTM 2.34b / Enterprise Value 82.54b)
FCF Margin = 19.91% (FCF TTM 2.34b / Revenue TTM 11.73b)
Net Margin = 14.19% (Net Income TTM 1.67b / Revenue TTM 11.73b)
Gross Margin = 27.81% ((Revenue TTM 11.73b - Cost of Revenue TTM 8.47b) / Revenue TTM)
Gross Margin QoQ = 30.16% (prev 30.47%)
Tobins Q-Ratio = 4.96 (Enterprise Value 82.54b / Total Assets 16.64b)
Interest Expense / Debt = 1.29% (Interest Expense 159.0m / Debt 12.35b)
Taxrate = 30.30% (183.0m / 604.0m)
NOPAT = 1.81b (EBIT 2.59b * (1 - 30.30%))
Current Ratio = 0.66 (Total Current Assets 3.12b / Total Current Liabilities 4.70b)
Debt / Equity = -2.50 (negative equity) (Debt 12.35b / totalStockholderEquity, last quarter -4.93b)
Debt / EBITDA = 4.09 (Net Debt 11.29b / EBITDA 2.76b)
Debt / FCF = 4.83 (Net Debt 11.29b / FCF TTM 2.34b)
Total Stockholder Equity = -4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.99% (Net Income 1.67b / Total Assets 16.64b)
RoE = -37.78% (negative equity) (Net Income TTM 1.67b / Total Stockholder Equity -4.41b)
RoCE = 36.00% (EBIT 2.59b / Capital Employed (Equity -4.41b + L.T.Debt 11.60b))
RoIC = 26.50% (NOPAT 1.81b / Invested Capital 6.81b)
WACC = 8.05% (E(71.25b)/V(83.60b) * Re(9.29%) + D(12.35b)/V(83.60b) * Rd(1.29%) * (1-Tc(0.30)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.55%
[DCF Debug] Terminal Value 80.35% ; FCFF base≈2.08b ; Y1≈2.44b ; Y5≈3.67b
Fair Price DCF = 218.1 (EV 62.00b - Net Debt 11.29b = Equity 50.71b / Shares 232.4m; r=8.05% [WACC]; 5y FCF grow 18.04% → 2.90% )
EPS Correlation: 2.95 | EPS CAGR: -36.25% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.51 | Revenue CAGR: 15.19% | SUE: 3.68 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.84 | Chg30d=-0.007 | Revisions Net=-4 | Analysts=16
EPS next Year (2026-12-31): EPS=9.15 | Chg30d=+0.018 | Revisions Net=+1 | Growth EPS=+13.3% | Growth Revenue=+7.7%
P/E Forward = 32.3625
P/S = 14.6298
P/EG = 1.6679
Revenue TTM = 11.73b USD
EBIT TTM = 2.59b USD
EBITDA TTM = 2.76b USD
Long Term Debt = 11.60b USD (from longTermDebt, last quarter)
Short Term Debt = 35.0m USD (from shortTermDebt, last quarter)
Debt = 12.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.29b USD (from netDebt column, last quarter)
Enterprise Value = 82.54b USD (71.25b + Debt 12.35b - CCE 1.06b)
Interest Coverage Ratio = 4.23 (Ebit TTM 2.59b / Interest Expense TTM 612.0m)
EV/FCF = 35.32x (Enterprise Value 82.54b / FCF TTM 2.34b)
FCF Yield = 2.83% (FCF TTM 2.34b / Enterprise Value 82.54b)
FCF Margin = 19.91% (FCF TTM 2.34b / Revenue TTM 11.73b)
Net Margin = 14.19% (Net Income TTM 1.67b / Revenue TTM 11.73b)
Gross Margin = 27.81% ((Revenue TTM 11.73b - Cost of Revenue TTM 8.47b) / Revenue TTM)
Gross Margin QoQ = 30.16% (prev 30.47%)
Tobins Q-Ratio = 4.96 (Enterprise Value 82.54b / Total Assets 16.64b)
Interest Expense / Debt = 1.29% (Interest Expense 159.0m / Debt 12.35b)
Taxrate = 30.30% (183.0m / 604.0m)
NOPAT = 1.81b (EBIT 2.59b * (1 - 30.30%))
Current Ratio = 0.66 (Total Current Assets 3.12b / Total Current Liabilities 4.70b)
Debt / Equity = -2.50 (negative equity) (Debt 12.35b / totalStockholderEquity, last quarter -4.93b)
Debt / EBITDA = 4.09 (Net Debt 11.29b / EBITDA 2.76b)
Debt / FCF = 4.83 (Net Debt 11.29b / FCF TTM 2.34b)
Total Stockholder Equity = -4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.99% (Net Income 1.67b / Total Assets 16.64b)
RoE = -37.78% (negative equity) (Net Income TTM 1.67b / Total Stockholder Equity -4.41b)
RoCE = 36.00% (EBIT 2.59b / Capital Employed (Equity -4.41b + L.T.Debt 11.60b))
RoIC = 26.50% (NOPAT 1.81b / Invested Capital 6.81b)
WACC = 8.05% (E(71.25b)/V(83.60b) * Re(9.29%) + D(12.35b)/V(83.60b) * Rd(1.29%) * (1-Tc(0.30)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.55%
[DCF Debug] Terminal Value 80.35% ; FCFF base≈2.08b ; Y1≈2.44b ; Y5≈3.67b
Fair Price DCF = 218.1 (EV 62.00b - Net Debt 11.29b = Equity 50.71b / Shares 232.4m; r=8.05% [WACC]; 5y FCF grow 18.04% → 2.90% )
EPS Correlation: 2.95 | EPS CAGR: -36.25% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.51 | Revenue CAGR: 15.19% | SUE: 3.68 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.84 | Chg30d=-0.007 | Revisions Net=-4 | Analysts=16
EPS next Year (2026-12-31): EPS=9.15 | Chg30d=+0.018 | Revisions Net=+1 | Growth EPS=+13.3% | Growth Revenue=+7.7%